• Revenue increased 17% to $44.1 million
• Net profit after tax reached $4.2 million, up 79%
• Improved trading conditions across Europe and ANZ
• Operational performance improved with increased customer demand

Clover Corporation Limited (Clover) has reported a revenue increase of 17% to $44.1 million (2025: $37.6 million) and a net profit after tax of $4.2 million for the half-year ended 31 January 2026 (2025: $2.4 million profit), marking significant growth from the same time last year. The strong financial performance was driven by Clover's product and market diversification strategy, improved market conditions, and strategic initiatives in product mix optimisation and manufacturing efficiencies. Clover experienced improved trading conditions across Europe and ANZ during the period, supported by increased demand from new and existing customers and continued expansion into broader human nutrition segments. Operational performance also improved in line with increased customer demand, with the Melody Dairies facility operating at capacity and the Ecuador extraction facility continuing to supply crude fish oil. Development of encapsulated choline for dry mix applications also progressed during the period. Clover's balance sheet remains strong, with a focus on raising inventory levels to meet increased customer demand, combined with debtor management and lower capital expenditure in the first half.

Revenue guidance for FY26 $92 to $96 million.

The Board anticipates that the positive momentum from the first half of FY26 will carry forward, resulting in a stronger second half, based on current demand forecasts. This outlook assumes that geopolitical tensions will not worsen and supply chains will remain stable.